Invasive Hemodynamics and Force-frequency Relationships in Open- Versus Closed-chest Mice
Overview
Affiliations
We compared hemodynamics, ventricular function, and force-frequency relationships in six open-chest and six closed-chest anesthetized mice (FVB/N strain). Left ventricular (LV) pressure was measured with a 1.8- or 1.4-Fr Millar catheter placed via the right carotid artery and the LV apex in the closed- and open-chest state, respectively. Pacing was performed with electrodes placed either directly on atrial appendages (open chest) or with a 1-Fr bipolar catheter via the jugular vein (closed chest). Closed-chest animals had greater spontaneous heart rate (267 +/- 106 vs. 147 +/- 27 beats/min), LV systolic (81 +/- 14 vs. 48 +/- 9 mmHg) and diastolic pressures (11.2 +/- 4.8 vs. 5.6 +/- 2.4 mmHg), and maximal rise (+ dP/dtmax: 6,208 +/- 2,519 vs. 3,682 +/- 671 mmHg/s) and fall in pressure development (-dP/dtmax: -6,094 +/- 2,386 vs. -3,001 +/- 399 mmHg/s). LV systolic pressure (98 +/- 18 vs. 52 +/- 11 mmHg), + dP/dtmax (9,240 +/- 2,459 vs. 5,777 +/- 2,473 mmHg/s), and -dP/dtmax (-8,375 +/- 2,551 vs. -3,753 +/- 1,170 mmHg/s) were significantly higher when animals were matched at a heart rate of 420 beats/min in closed-chest vs. open-chest animals. Biphasic force-frequency relationships were seen in all animals, but the critical heart rate was greater in the closed- than open-chest animals (432 +/- 42 vs. 318 +/- 42 beats/min). We conclude that 1) there are significant differences between invasive indexes of systolic and diastolic function between the closed- and open-chest preparations, 2) there is a biphasic force-frequency relationship in the anesthetized mouse, and 3) dP/dtmax can be used to assess the cardiovascular phenotype.
Rajanathan R, Pedersen T, Thomsen M, Botker H, Matchkov V Front Physiol. 2022; 13:831724.
PMID: 35250634 PMC: 8891648. DOI: 10.3389/fphys.2022.831724.
Kwan E, Velez-Rendon D, Zhang X, Mu H, Patel M, Pursell E Am J Physiol Heart Circ Physiol. 2021; 321(4):H702-H715.
PMID: 34448637 PMC: 8794227. DOI: 10.1152/ajpheart.00046.2021.
Gufler H, Niefeldt S, Boltze J, Prietz S, Klopsch C, Wagner S J Cardiovasc Transl Res. 2019; 12(5):459-466.
PMID: 30847657 DOI: 10.1007/s12265-019-09881-6.
Optimizing Cardiac Delivery of Modified mRNA.
Sultana N, Magadum A, Hadas Y, Kondrat J, Singh N, Youssef E Mol Ther. 2017; 25(6):1306-1315.
PMID: 28389322 PMC: 5474881. DOI: 10.1016/j.ymthe.2017.03.016.
Long D, Zhu H, Friedman M J Biomed Opt. 2013; 18(9):096013.
PMID: 24057233 PMC: 3779146. DOI: 10.1117/1.JBO.18.9.096013.